Professional Summary

Professional Overview

Susan Roaf is an experienced Chief Financial Officer with a strong track record of driving financial strategy and operational excellence. She specializes in the pharmaceutical and healthcare industry, utilizing her technical expertise and leadership capabilities to enhance organizational performance and profitability.

Experience Summary

Current Role

As the Chief Financial Officer at Johnson & Johnson, Susan is responsible for overseeing all financial operations, including budgeting, cash flow management, financial reporting, and risk mitigation. She has been instrumental in implementing innovative financial processes that have improved the company's bottom line by 12% over the past three years. Under her leadership, the finance team has also streamlined operations, resulting in a 20% increase in efficiency.

Career Progression

Prior to her current role, Susan served as a Finance Assistant and Intern Assistant at DWS Group, where she gained valuable experience in financial analysis, data management, and cross-functional collaboration. Her strong work ethic and problem-solving skills propelled her rapid career advancement, culminating in her appointment as the Chief Financial Officer at Johnson & Johnson in 2017.

Academic Background

Susan holds a Bachelor of Science in Accounting from the University of California, Los Angeles, where she graduated with Honors. She is also a Certified Public Accountant (CPA) and has completed advanced coursework in financial management and strategic decision-making.

Areas of Expertise

• Financial planning and analysis

• Cash flow management and forecasting

• Financial reporting and compliance

• Risk assessment and mitigation

• Process improvement and operational efficiency

• Cross-functional collaboration and team leadership

Professional Impact

During her tenure as Chief Financial Officer, Susan has spearheaded several key initiatives that have significantly impacted the organization. She led the implementation of a new enterprise resource planning (ERP) system, which resulted in a 25% reduction in administrative costs and improved data visibility across the company. Additionally, she played a crucial role in the successful integration of a major acquisition, ensuring a seamless transition and preserving shareholder value.

Conclusion

With her exceptional financial acumen, strategic vision, and proven track record of driving organizational success, Susan Roaf is a highly sought-after Chief Financial Officer. Her ability to navigate complex financial challenges, foster collaborative partnerships, and deliver tangible results make her a valuable asset to any organization in the pharmaceutical and healthcare industry.